American Healthcare REIT, Inc. (AHR)

American Healthcare REIT, Inc. (AHR) is a Real Estate Investment Trust with a market cap of approximately $9.66B, trading around $50.10 per share. Despite its REIT classification, the data provided attributes an extraordinarily eclectic and incoherent drug pipeline to the company — spanning iron deficiency anemia, oncology, pain, and urology — which almost certainly reflects a data artifact or misattribution rather than AHR's actual business. AHR's financials show a growing revenue base ($2.26B in 2025) with a recent return to profitability ($70M net income in 2025 after years of losses), consistent with a healthcare real estate operator, not a drug developer.